Syndax Pharmaceuticals Ownership | Who Owns Syndax Pharmaceuticals?
Syndax Pharmaceuticals Ownership Summary
Syndax Pharmaceuticals is owned by 61.46% institutional investors, 1.84% insiders, and 36.70% retail investors. Kynam capital management, lp is the largest institutional shareholder, holding 9.87% of SNDX shares. Vanguard Health Care Inv is the top mutual fund, with 3.50% of its assets in Syndax Pharmaceuticals shares.
SNDX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Syndax Pharmaceuticals | 61.46% | 1.84% | 36.70% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Kynam capital management, lp | 8.52M | 9.87% | $131.08M |
| Blackrock funding, inc. /de | 8.24M | 9.51% | $173.10M |
| Blackrock | 7.91M | 9.28% | $162.33M |
| Vanguard group | 6.23M | 7.19% | $130.90M |
| Goldman sachs group | 5.70M | 6.58% | $119.66M |
| Point72 asset management | 4.26M | 4.93% | $65.46M |
| State street | 3.85M | 4.46% | $59.29M |
| Eversept partners, lp | 3.47M | 4.02% | $53.34M |
| Adage capital partners gp | 3.31M | 3.84% | $50.95M |
| Kingdon capital management | 2.50M | 2.90% | $38.46M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kynam capital management, lp | 8.52M | 9.76% | $131.08M |
| Aisling capital management lp | 1.32M | 5.78% | $27.67M |
| Lion point capital, lp | 55.00K | 4.81% | $846.17K |
| Kingdon capital management | 2.50M | 4.77% | $38.46M |
| Catalio capital management, lp | 1.61M | 4.59% | $24.84M |
| Stempoint capital lp | 1.37M | 4.21% | $21.02M |
| Knott david m jr | 415.00K | 4.04% | $8.72M |
| Eversept partners, lp | 3.47M | 3.68% | $53.34M |
| Bioimpact capital | 1.38M | 3.46% | $21.16M |
| Prosight management, lp | 665.00K | 2.89% | $13.97M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Point72 asset management | 4.26M | 0.11% | 2.13M |
| Adage capital partners gp | 3.31M | 0.08% | 1.88M |
| Bioimpact capital | 1.38M | 3.46% | 1.38M |
| Vanguard group | 6.23M | 0.00% | 1.09M |
| Ensign peak advisors | 1.60M | 0.06% | 789.48K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Avoro capital advisors | - | - | -2.27M |
| Orbimed advisors | - | - | -1.93M |
| Bvf inc/il | - | - | -1.88M |
| Assenagon asset management | 41.74K | 0.00% | -1.74M |
| Balyasny asset management | 126.14K | 0.00% | -1.69M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Bioimpact capital | 1.38M | 3.46% | 1.38M | $21.16M |
| Apis capital advisors | 638.00K | 2.17% | 638.00K | $9.82M |
| Ikarian capital | 333.73K | 0.52% | 333.73K | $5.13M |
| Canada pension plan investment board | 229.60K | 0.00% | 229.60K | $3.53M |
| Velan capital investment management lp | 130.00K | 1.88% | 130.00K | $2.00M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Nelson, van denburg & campbell wealth management group | -13.00 |
| Riggs asset managment | -26.00 |
| Svb wealth | -27.00 |
| Stephens consulting | -30.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 166 | -32.52% | 53,238,549 | -47.45% | 61 | 0.45% | 78 | -39.06% | 46 | -34.29% |
| Sep 30, 2025 | 238 | 5.78% | 101,267,970 | 8.78% | 117 | 1.01% | 123 | 6.03% | 69 | 13.11% |
| Jun 30, 2025 | 232 | - | 101,730,191 | 1.68% | 117 | 0.86% | 116 | -3.33% | 65 | 1.56% |
| Mar 31, 2025 | 233 | 2.19% | 100,944,775 | 2.97% | 117 | 0.90% | 119 | -7.03% | 65 | 10.17% |
| Dec 31, 2024 | 216 | -5.68% | 91,955,124 | 3.35% | 107 | 0.99% | 119 | -4.03% | 58 | -1.69% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Health Care Inv | 2.99M | 3.50% | - |
| State Street® SPDR® S&P® Biotech ETF | 2.79M | 3.20% | -14.94K |
| Vanguard Total Stock Mkt Idx Inv | 2.73M | 3.12% | 9.46K |
| Vanguard US Total Market Shares ETF | 2.60M | 3.01% | 4.69K |
| iShares Russell 2000 ETF | 2.05M | 2.34% | 937.29K |
| SPDR® S&P Biotech ETF | 1.54M | 1.78% | 3.43K |
| Hood River Small-Cap Growth Instl | 1.21M | 1.39% | 1.21M |
| Franklin Biotechnology Discv A(acc)USD | 1.02M | 1.16% | - |
| Eventide Healthcare & Life Sciences I | 988.43K | 1.13% | -425.65K |
| Vanguard Institutional Extnd Mkt Idx Tr | 940.39K | 1.08% | -878.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 09, 2026 | Metzger Michael A | Chief Executive Officer | Sell | $360.82K |
| Feb 09, 2026 | Goldan Keith A. | Chief Financial Officer | Sell | $71.71K |
| Feb 06, 2026 | Metzger Michael A | Chief Executive Officer | Sell | $152.84K |
| Feb 06, 2026 | Goldan Keith A. | Chief Financial Officer | Sell | $42.93K |
| Sep 08, 2025 | Metzger Michael A | Chief Executive Officer | Sell | $2.58M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 4 |
| 2025 Q4 | - | - |
| 2025 Q3 | - | 6 |
| 2025 Q2 | 4 | - |
| 2025 Q1 | - | 4 |
SNDX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools